MediFind

Find a Doctor

Takashi G. Sato

Yokohama City University Graduate School Of Medicine
Male

Bio


Takashi Sato is in Nagano, Japan. They have been an author on 257 peer reviewed articles in the past 15 years. Dr. Sato's top three areas of expertise are Silicosis, Lung Cancer, and Lung Adenocarcinoma.

Contact

Nagano, 39945, JP

Latest Research


Latest Advance
Study
  • Condition: EGFR Mutation-Positive Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Cancer chemotherapy and pharmacology
  • Treatment Used: Erlotinib followed by Cytotoxic Chemotherapy
  • Number of Patients: 20
  • Published —
This study evaluated the treatment order and timing of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and cytotoxic chemotherapy administration for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC).

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Nagano, 39945, JP

Insurance

Contact them to find out if they accept your insurance plan.